Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_assertion type Assertion NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_head.
- NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_assertion wasGeneratedBy ECO_0000203 NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_provenance.
- NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_assertion wasDerivedFrom lhgdn-20090331 NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_provenance.
- NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_assertion SIO_000772 19139306 NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_provenance.
- NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_assertion evidence source_evidence_literature NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_provenance.
- NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_provenance.